🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My student accepted a fully funded PhD in the US, but has had difficulty securing an appointment with the US consulate in Italy. They are now drafting materials for an expedited interview request. If you have advice/materials on how to secure an expedited interview please dm me

Hello Xverse, we're on the hunt for a postdoctoral fellow to study cellular and systemic metabolism with a quantitative, multimodal toolkit. Is this you or someone you know and love? Reach out!

How do healthy tissues evolve to become cancerous? Delighted to share our latest research tracking the somatic evolution that occurs in the decades before AML. 👇Implications for early detection and early interception. biorxiv.org/cgi/content/sh…

The interplay between proliferating pathogens and the huge diversity of immune receptors, makes the problem of antigen recognition very interesting. The stat mech density of states + noneq binding give a nice framework to study it. Check it out Physical Review X journals.aps.org/prx/abstract/1…

We posted a couple of preprints recently, quick summary below 👇

New preprint led by postdoc Brandon Schlomann discovering spatial patterns of immune response in fly larvae! biorxiv.org/content/10.110…

Fun project working with Trevor GrandPre and David! In a nutshell -- in eco-evo contexts, different types of mutational processes can drive different qualitative behavior, including pattern formation a la Turing. Check out the preprint if this sounds interesting to you!

1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity   But how? What molecule triggers? What cells induce?   TODAY in nature nature.com/articles/s4158…   Long-term #PDAC survivor PART4 – TLSs   🧵1/25

I am thrilled to see our latest findings out in nature -we identify that IL33 induces Tertiary Lymphoid structure via ILC2s. -we show that this pathway is druggable and engineered human rIL33 as potentially a novel immunotherapy! I am glad to have led this study with

Our latest work on the #darkgenome is out now in Nature Communications. LINE-1 is the only known autonomous retrotransposon in our genome - an ancient genome parasite that can start replicating again in cancer. Co-led by our Alexander Solovyov Memorial Sloan Kettering Cancer Center The Halvorsen Center for Computational Oncology - our work was

🚨 Just out Nature Medicine! Introducing InflaMix—a point-of-care tool that identifies an #inflammatory 🔥 signature predictive of #CART failure in #lymphoma Led by Sandeep Raj (Sandeep Raj) 👏Memorial Sloan Kettering Cancer Center nature.com/articles/s4159… 🧵Let’s break it down

Excited to join WashU Physics as an assistant professor in Fall 2025! My group will develop non-equilibrium statistical physics to study criticality in biology—biomolecular condensates, gene regulation & adaptive immune systems. DM for postdoc/grad openings! #myphysicsjourney

#Preprint alert! Kevin (Yan-Ting) Chen, a brilliant GSK Graduate School graduate student and NCI F99/K00 awardee, identifies a novel, post-transcriptional checkpoint on intratumoral T cell function: biorxiv.org/content/10.110…

#Preprint alert! Pioneering work by Tanmana Mitra sheds new insights into why T cells become metabolically exhausted during persistent antigen encounter: biorxiv.org/content/10.110…